Price $178.66 |
Market Cap
27.02B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
55.3
|
P/B
8.18
|
P/S
12.98
|
Dividend %
-
|
|
P/CF
388.7
|
P/FCF
39.4
|
Op. Cash Flow
741.4K
|
FCF
4.5
|
|
Op. Margin
22.30%
|
Net Margin
18.30%
|
ROE
12.50%
|
ROI
14.40%
|
|
ROA
9.80%
|
EPS Growth
-10.00%
|
Current Ratio
3.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cidara Therapeutics Inc (CDTX) | $1.26 | - | - | 129.6M | Strong Buy |
| DURECT Corp (DRRX) | $4.32 | - | - | 110.1M | Strong Buy |
| Dynatronics Corp (DYNT) | $1.56 | - | - | 7.4M | Strong Buy |
| PetIQ Inc (PETQ) | $11.44 | - | - | 315.7M | Strong Buy |
| Avalo Therapeutics Inc (AVTX) | $1.61 | - | - | 32.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
